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Materials
Media components and all chemical reagents were purchased from Sigma-Aldrich and used without purification, except for aldehydes, which were freshly purified by distillation prior to use. Organic solvents were of analytical grade. HPTLC analysis was performed on silica gel F 254 plates (Merck) using a CAMAG Automatic TLC Sampler 4 and CAMAG TLC Scanner 4. Screening consumables (96-well microtiter plates, acetate foil, pipette tips) where purchased from Sarstedt. Plates were incubated in an Infors Ecotron shaker. Synthetic oligonucleotides were purchased from Sigma-Aldrich. Triose phosphate isomerase/glycerol-3-phosphate dehydrogenase (mix from rabbit muscle) and NADH were purchased from Sigma-Aldrich. Proteinase K (Tritirachium album) came from Serva. Antibiotics, acrylamide-bisacrylamide and buffer components were from Carl Roth. Milli-Q grade water was used for preparations of buffers, whereas other assay solutions were obtained from an Arium Pro Ultrapure Water Purification System (Sartorius Stedim Biotech). Bacterial strains, oligonucleotides and plasmids used in this study are listed in Table 1 . The plasmid pET16b fsa containing the FSA gene for expression (gene code, fsa, formerly termed mipB [1] ) was constructed using routine cloning procedures. Gene sequencing was performed by GATC Biotech AG. Protein concentration was determined according to the Bradford method using commercial reagent (Carl Roth).
General procedure for mutagenesis and transformation
Mutagenesis of D-Fructose-6-phosphate aldolase (fsa) was performed by using the QuikChange site-directed mutagenesis kit (Agilent), using the plasmids pET16b fsa or pQE40 fsa as template. The specific combination of oligonucleotides and templates used are compiled in Table 1 . Competent cells of E. coli XL10 (Agilent) were used for transformation and plasmid preparation, and E. coli strain BL21 (DE3) [2] was used for protein expression. Plasmid DNA was isolated using the GenElute™ HP Plasmid Miniprep Kit (Sigma-Aldrich). The expected mutations in the gene sequence were confirmed by DNA sequencing. 
Correlated mutation analysis using 3DM
The 3DM database was created for the aldolase superfamily by first superpositioning of all published aldolase structures to determine a common core of structurally equivalent positions, followed by subfamily alignment of all protein sequences with >30% sequence identity, then merging all subfamilies into a fully aligned database according to their core residue positions. The database was interrogated for correlated mutations for the D6 and T26 sites, separately for collections containing (1) all aldolases, (2) all FSA-type enzymes, (3) all enzymes comprising a mechanistic water molecule for nucleophile activation/Schiff-base formation and release, and (4) all enzymes having a Schiff-base forming K78 residue.
A)
7 B) C) 
Site directed mutagenesis and library creation
The mutant fsa D6A was obtained using pET16b fsa as templates with the mutagenesis primers FSA D6A. BL21 (DE3) cells were transformed with this plasmid to heal the plasmid nicks. One of the colonies was cultivated in LB media overnight for plasmid isolation. The mutant fsa D6A/T26I was obtained using this pET16b fsa D6A as templates in a new PCR with the mutagenesis primers FSA T26I. The mutant fsa D6L was obtained using pET16b fsa as templates and the mutagenesis primers FSA D6L.
The library D6L/N28X was created with the N28X primer mixture and pET16b fsa D6L as template. The library D6E/N28X was created with the N28X primer mixture and pQE40 fsa D6E as template. The library D6H/N28X was created with the N28X primer mixture and pQE40 fsa D6H [3] as template. The variants D6H/N28D, D6H/N28L and D6H/N28T were created with the N28D, N28L or N28T primer mixtures and pQE40 fsa D6H [3] as template.
To create the D6X/T26X double site library pET16b fsa was used as a template in a PCR reaction with the D6X primer mixture. XL10 Gold cells were transformed with the resulting mix to heal the plasmid nicks and grown in LB media. From the mixed culture plasmid DNA was isolated to be used as a template in a second PCR reaction with the T26X primer mixture. The resulting plasmid mixture was sequenced for confirmation of the mutagenesis (Figure 1. ) and used to transform BL21 (DE3) cells to create the final library. 
96-well protein expression to create a screening plate
A fresh 96-deepwell plate with LB-medium (950 µl/well) was inoculated from the master plate and incubated at 30 °C and 230 rpm for 18 h. The cells were centrifuged (2540 × g for 30 min), the supernatant was discarded, and cells resuspended in LB media (950 µL/well) containing IPTG (0.5 mM) at 2500 rpm. After 18 h incubation at 30 °C (230 rpm), cells were harvested (2540 × g for 30 min) and suspended in TEA buffer (50 mM, pH 8.5, 500 µL/well).
Cell growth in Eppendorf vials
In an Eppendorf vial (2 mL) LB media (1.6 mL) was inoculated with BL21 (DE3) cells containing the appropriate expression plasmid and cultivated for 18 h at 37 °C. After centrifugation (16000 × g, 30 sec) the cell pellets were resuspended in LB media (1.6 mL) containing IPTG (0.5 mM). The vials were incubated for 6 h (37 °C) and then centrifuged (16000 × g, 30 sec).
Cell growth in shake flasks
E. coli strain Bl21 (DE3) was transformed with the appropriate expression plasmid. Cells were grown in auto induction media [4] (AI; 4 L) containing ampicillin (100 mg L -1 ) for 20 h at 37 ºC. Cells were harvested, suspended in TEA buffer (300 mL, 50 mM, pH 8.5) and centrifuged (2540 × g for 30 min). The cell pellet was resuspended in TEA buffer (200 mL, 50 mM, pH 8.5) and then lyophilized.
Protein expression and purification for preparative use
For expression of the FSA wt and the mutant proteins E. coli strain BL21 (DE3) was transformed with the corresponding plasmids. Cells were grown in AI medium (4 L) containing ampicillin (100 mg L -1 ) for 22 h at 37 ºC. Cells were harvested by centrifugation (2254 × g, 30 min) and suspended in 200 mL buffer solution (50 mM TEA, pH 8.5 for synthesis; 50 mM GlyGly, pH 7.0 for inhibition studies) containing lysozyme (1600 kU). Cell suspension was frozen at -20 °C. After thawing up to room temperature DNAse (800 U) and DTT (2 mM) were added. After incubation for 0.5-1 h cellular debris was removed by centrifugation (2540 × g for 30 min). The clear supernatant was purified by heat-shock treatment (70 ºC, 30 min) followed by centrifugation (16000 × g for 10 min). The supernatant was separated and lyophilized.
TLC screening of FSA D6H/N28L and D6H/N28T against D6H
The cells grown in an Eppendorf vial were resuspended in TEA buffer (0.5 mL, 50 mM, pH 8.0) and mixed with a stock solution of acetone and propanal for final concentrations of 1230 mM and 75 mM. [5] . 
TLC screening of N28X libraries

Screening of 96-well plates by thin layer chromatography
The cell supensions in the 96-well screening plate were mixed with a stock solution of acetone and propanal for final concentrations of 1230 mM and 75 mM. After incubation for 6 h (37 °C, 1200 rpm) samples of 2.3 µL from each well were removed and analysed by TLC (EtOAc/cyclohexane, 1:1). Staining was performed with anisaldehyde solution.
7.2
Screening of single-site FSA D6L/N28X library Variants with green rectangles were picked for the rescreening master plate; the variant with orange rectangles were sequenced but accidentally not continued for rescreening (duplicate entries).
All the variants marked in green were collected from the master plates to create a new rescreening master plate. From this master hit plate new screening plates were produced.
Rescreening
The cell suspensions in the 96-well hit plate were mixed with a stock solution of acetone and propanal for final concentrations of 1230 mM and 75 mM. After incubation for 6 h (37 °C, 1200 rpm) samples of 2.3 µL from each well were removed and analysed by TLC (EtOAc/cyclohexane, 1:1). Staining was performed with anisaldehyde solution. 
Screening with n-butanal
The cell suspensions in the 96-well hit plate were mixed with n-butanal for a final concentration of 110 mM. After incubation for 6 h (rt, 1200 rpm) samples of 2.3 µL from each well were removed and analysed by TLC (EtOAc/cyclohexane, 1:1). Staining was performed with anisaldehyde solution. 9 Sequencing results from the D6X/N28X library screenings A09  D6V  T26V  D05  D6L T26A  G01  D6A  wt   A10  D6A  wt  D06  D6A T26A  G02  D6L  T26I   A11  D6L  wt  D07  wt  T26L  G03  wt  T26V   A12  D6L  T26A  D08  Wt  T26I  G04  D6H  T26A   B01  D6Q  T26L  D09  D6A T26I  G05  D6H  T26L   B02  D6H  T26L  D10  D6A T26V  G06  D6V  T26A   B03  D6L  T26L  D11  D6A wt  G07  D6A  T26V   B04  D6A  T26V  D12  D6P T26P  G08  D6E  wt   B05  D6E  wt  E01  D6Q T26L  G09  D6A  T26I   B06  D6E  T26L  E02  Wt  T26I  G10  D6A  wt   B07  D6V  T26A  E03  D6V T26P  G11  D6V  T26A   B08  D6H  wt  E04  D6E T26A  G12  D6V  T26A   B09  D6A  T26L  E05  D6A wt  H01  D6H  wt   B10  D6E  T26V  E06  D6H T26L  H02  D6P  T26L   B11   [b]   wt  wt  E07  D6V T26L  H03  D6A  T26I   B12  D6L  T26V  E08  wt  T26I  H04  D6H  T26L   C01  D6H  T26A  E09  D6E T26V  H05  D6V  T26L   C02  D6A  T26A  E10  D6A wt  H06  D6E  T26L   C03  D6L  wt  E11  D6A T26I  H07  D6L  T26V   C04  D6V  T26L  E12  D6P wt  H08  D6V  T26L   C05  D6A  T26L  F01  D6E T26I  H09  D6A  T26V   C06  D6L  T26V  F02  wt  wt  H10  D6A  wt   C07  D6E  T26A  F03  D6L T26A  H11  D6A  wt   C08  D6A  wt  F04  D6L T26A  H12  D6Q  T26I [a] = mixture of variants; [b] = false positive (FSA wt); [c] = start codon mutated. Color code for variants: green selective for 4-hydroxyhexan-2-one, blue for 3-hydroxy-2-methylpentanal, black non-selective, red inactive.
All unique positive mutants were collected in one 96-well master plate to build the hit library for subsequent screenings. 10 High performance TLC screening with acetone and propanal
The cell supensions in the 96-well hit plate were mixed with a stock solution of acetone and propanal for final concentrations of 1230 mM and 75 mM. After incubation for 6 h (37 °C, 1200 rpm) cells were centrifuged (2250 × g, 30 min) and samples of 50 µL/well were transferred to a new plate and mixed with 50 µL MeOH per well. After shaking (1200 rpm) for 20 sec, the plate was centrifuged (2250 × g, 30 min). A sample from the liquid phase of each well (4 µL) was sprayed with 6 mm band width on TLC plates, which were developed with EtOAc/cyclohexane (1:1, v/v). Staining was performed by dipping into an anisaldehyde reagent solution followed by heating in an oven at 110 °C for 90 sec. Plates were densitometrically analysed at 600 nm using the CAMAG-Scanner. 
High performance TLC analysis for propanal self aldolization
The cell supensions in the 96-well hit plate were mixed with propanal for a final concentration of 75 mM. After incubation for 6 h (37 °C, 1200 rpm) cells were centrifuged (2250 × g, 30 min) and samples of 50 µL/well were transferred to a new plate and mixed with 50 µL MeOH per well. After shaking (1200 rpm) for 20 sec, the plate was centrifuged (2250 × g, 30 min). A sample from the liquid phase of each well (4 µL) was sprayed with 6 mm band width on TLC plates, which were developed with EtOAc/cyclohexane (1:1, v/v). Staining was performed by dipping into an anisaldehyde reagent solution followed by heating in an oven at 110 °C for 90 sec. Plates were densitometrically analysed at 615 nm using the CAMAG-Scanner. 
High performance TLC analysis for acetone and isopentanal
The cell supensions in the 96-well hit plate were mixed with acetone and isopentanal for final concentrations of 1230 mM and 75 mM, respectively. After incubation for 6 h (37 °C, 1200 rpm) cells were centrifuged (2250 × g, 30 min) and samples of 50 µL/well were transferred to a new plate and mixed with 50 µL MeOH per well. After shaking (1200 rpm) for 20 sec, the plate was centrifuged (2250 × g, 30 min). A sample from the liquid phase of each well (4 µL) was sprayed with 6 mm band width on TLC plates, which were developed with EtOAc/cyclohexane (1:1, v/v). Staining was performed by dipping into an anisaldehyde reagent solution followed by heating in an oven at 110 °C for 90 sec. Plates were densitometrically analysed at 450 nm using the CAMAG-Scanner. 13 Synthesis and NMR spectroscopic analysis
Synthesis of (R)-4-hydroxyhexan-2-one
In the reaction vessel lyophilized whole cells of E. coli BL21, previously cultivated for expression of FSA D6E (250 mg, equivalent to 15 mg of pure FSA) were suspended in PBS buffer (15 mL, pH 7.0). Acetone (4 mL, 54.5 mmol), freshly distilled propanal (1 mL, 13.9 mmol), and DTT (2 mM) were added. The suspension was shaken on a rotary shaker at 21 °C for 4 days, then centrifuged at 3087 × g for 20 min. The supernatant was extracted with diethyl ether (3 x 20 mL), and the combined organic layers were dried over MgSO 4 , filtered, and the solvent evaporated under vacuum. The oily residue containing almost pure product (550 mg, 33.9%) was analyzed by NMR spectroscopy. 
Synthesis of (R)-4-hydroxy-6-methylheptan-2-one
In the reaction vessel lyophilized whole cells of E. coli BL21, previously cultivated for expression of FSA D6E (191 mg, equivalent to 11 mg of pure FSA) were suspended in PBS buffer (15 mL, pH 7.0). Acetone (4 mL, 54.5 mmol), freshly distilled isopentanal (1 mL, 9.3 mmol), and DTT (2 mM) were added. The suspension was shaken on a rotary shaker at 21 °C for 4 days, then centrifuged at 3087 × g for 20 min. The supernatant was extracted with diethyl ether (3 x 20 mL), and the combined organic layers were dried over MgSO 4 , filtered, and the solvent evaporated under vacuum. The oily residue, containing almost pure product (284 mg, 21.2%), was analyzed by NMR spectroscopy.
Figure 16.
1 H NMR spectrum of (R)-4-hydroxy-6-methylheptan-2-one from acetone and isovaleraldehyde
Synthesis of (2R,3R)-2-methylpentane-1,3-diol
The enzyme catalyst FSA D6A/T26I (35 mg) was dissolved in triethanolamine buffer (100 mL; 50 mM, pH 7.4) containing DTT (2 mM). After addition of freshly distilled propanal (1500 µL, 20.9 mmol) the vessel was stoppered and reaction mixture stirred at 20 °C for 3 days. Then CaCl 2 solution was added (1 mM final concentration) followed by proteinase K (51 U) [6] , and the pH adjusted to 7.0 using sat. aq NaHCO 3 solution. This mixture was incubated at 55 °C for 2 h during which the turbid solution became clear. The product was extracted with ethyl acetate (4 × 60 mL) with TLC control. The combined organic layers were dried (MgSO 4 ), filtered, and the solvent evaporated at 40 °C under vacuum. The oily residue was purified by silica column chromatography using cyclohexane-ethyl acetate (3:1) as eluent. The aldehyde (1 eq) was dissolved in MeOH (1.4 mL per mmol aldehyde) and treated portion wise with NaBH 4 (1.5 eq per mmol) with stirring at room temperature. After 2 h, 2 volumes of brine were added and a solid precipitated. The mixture was slowly treated with deionized water until the turbidity disappeared (ca. 4 mL/mL MeOH). The solution was extracted with ethyl acetate (6 × 20 mL; TLC control). The combined organic phases were dried (MgSO 4 ), filtered and concentrated under vacuum at 40 °C to give 130 mg pure product (10.6 %). 
Synthesis of (3R)-2-methylpentane-1,3-diol
The enzyme catalyst FSA D6A/T26L (15 mg) was dissolved in triethanolamine buffer (200 mL, 50 mM, pH 7.4) containing DTT (2 mM). After addition of freshly distilled propanal (1.6 g, 27.89 mmol) the vessel was stoppered and reaction mixture stirred at 20 °C for 3 days. Work-up was performed as above to furnish the aldol product as an oily residue. The residue was dissolved in alkaline buffer (pH 9.0), allowed to stand for 10 min, and then reduced with NaBH 4 and worked up as above. The yellow oily residue gave the title compound (7.7 %) as a mixture of diastereoisomers, which was analyzed by NMR spectroscopy. The ratio of (2R,3R) to (2S,3R) or syn/anti was found to be ca. 1:2. 
Synthesis of (4R,5R)-4-ethyl-2,2,5-trimethyl-1,3-dioxane
A sample of the diol was taken up in dry acetone (2.5 mL) followed by addition of dimethoxypropane (2.5 mL). To this was added molecular sieves (250 mg; 3 Å) and a catalytic quantity of p-TosOH. The vessel was closed with a septum and stirred at 20 °C for 2.5 h. After addition of satd NaHCO 3 solution (2.5 mL) the mixture was extracted using diethyl ether (3 × 5 mL). [7] The combined organic phases were dried (MgSO 4 ), filtered and concentrated under vacuum to furnish the acetal as an oil (300 mg, 29.9 %). 
Synthesis of (4R)-4-ethyl-2,2,5-trimethyl-1,3-dioxane
The crude diastereomeric mixture of (3R)-2-methylpentane-1,3-diol synthetized above (1570 mg, 13.29 mmol) was taken up in dry acetone (38 mL) followed by addition of dimethoxypropane (38 mL). To this was added molecular sieves (7 g; 3 Å) and a catalytic quantity of p-TosOH. The vessel was closed with a septum and stirred at 20 °C for 2.5 h. After addition of satd NaHCO 3 solution (38 mL) the mixture was extracted with diethyl ether (3 × 80 mL). [7] The combined organic phases were dried (MgSO 4 ), filtered and concentrated under vacuum to furnish the acetal as an oil (384 mg, 18.2 %). Published NMR spectra for the (4R,5S)-configured acetal [7] prove the assignments Figure 22 . Comparison of 
Synthesis of (4R,5R)-5-ethyl-2,2-dimethyl-4-propyl-1,3-dioxane
The enzyme catalyst FSA D6A/T26L (35 mg) was dissolved in triethanolamine buffer (100 mL; 50 mM, pH 7.4) containing DTT (2 mM). After addition of freshly distilled butanal (400 µL, 20.9 mmol) the vessel was stoppered and reaction mixture stirred at 20 °C for 3 days. Then CaCl 2 solution was added (1 mM final concentration) followed by proteinase K (51 U), and the pH adjusted to 7.0 using satd aq NaHCO 3 solution. This mixture was incubated at 55 °C for 2 h during which the turbid solution became clear. The product was extracted using ethyl acetate (4 x 60 mL) with TLC control. The combined organic layers were dried (MgSO 4 ), filtered, and the solvent evaporated at 40 °C under vacuum. The oily residue was purified by silica column chromatography using cyclohexane-ethyl acetate (3:1) as eluent to give pure product (90 mg, 26.9%). For stereochemical analysis, the aldehyde (1 eq) was dissolved in MeOH (1.4 mL per mmol aldehyde) and treated portion wise with NaBH 4 (1.5 eq per mmol) with stirring at room temperature. Work-up and acetal protection using dimethoxypropane in acetone with acid catalysis was essentially performed as above. Extraction of product was performed using cyclohexane, and purification was achieved by silica gel column chromatography (ethyl acetatecyclohexane 1:10). 
Synthesis of (4R)-5-ethyl-2,2-dimethyl-4-propyl-1,3-dioxane with FSA
The diastereomer mixture was created by epimerization of C5 using base treatment of the aldol product in solution as above, followed by standard reduction and acetal protection (yield 93 mg, 73.5 %).
Figure 24.
1 H NMR spectrum of diastereomeric mixture of (4R)-5-ethyl-2,2-dimethyl-4-propyl-1,3-dioxane
Synthesis of racemic 4-hydroxyhexan-2-one
A gas washing bottle was filled with propanal (12 mL), then connected to a second gas washing bottle filled with acetone (94 mL) and methanolic KOH solution (1 M, 6 mL) at -5 °C. A gentle stream of nitrogen was passed through the propanal bottle in order to slowly carry the aldehyde over into the acetone solution. When the propanal had completely evaporated, a solution of oxalic acid (300 mg in 10 mL MeOH, 2.38 mmol) was added to the reaction mixture for neutralization, upon which potassium oxalate precipitated. After filtration, remaining acetone was evaporated under vacuum. The remaining liquid was distilled at 10 mbar to give a mixture of 4-hydroxyhexan-2-one and 4-hydroxy-4-methylpentan-2-one (from self-aldol addition of acetone), which was used as a GC reference sample without further purification. 
Relative activity of different FSA variants in the formation of 4-hydroxyhexan-2-one
The fsa mutants D6L, D6L/T26A, D6A and D6E from the hit library were cultivated in 1.6 mL LB media (18 h, 30 °C, 900 rpm). After centrifugation (16000 × g, 30 sec) the cell pellets were resuspended in 1.6 mL LB media containing IPTG (0.5 mM) and incubated for 6 h (37 °C, 900 rpm). The cells were collected by centrifugation (16000 × g, 30 sec) and resuspended in TEA buffer (2 mL, 50 mM, pH 8.3), then propanal (40 mM) and acetone (680 mM) were added and the mixtures were incubated at room temperature. After periods of 40, 90 and 140 min the cells were removed by centrifugation (16000 × g, 30 sec) and an aliquot of the reaction volume (100 µL) was mixed with MeOH (900 µL). After 5 min this mixture was again centrifuged (16000 × g, 30 sec) and analyzed by GC. [a] Color code: blue = selective for 3-hydroxy-2-methylpentanal, green = selective for 4-hydroxyhexan-2-one 
Kinetic analysis of propanal / butanal homoaldolization by FSA variant D6A/T26L
Lyophilized FSA D6A/T26L (21 mg) was dissolved in 200 mL of TEA buffer (50 mM, pH 7.4) containing DTT (2 mM). The solution was devided into two equal portions; one was charged with propanal (1.6 mL, 223 mM), the other with n-butanal (2.0 mL, 221 mM). Both reaction mixtures were gently stirred at room temperature. At certain intervals, samples (100 µL) were withdrawn from each vessel, diluted with MeOH (900 µL), centrifuged and analyzed for product formation by GC. 16 D-F6P assay for inhibitor identification [8] Assay components D-F6P (30 mM), NADH (125 nM), triosephosphate isomerase (13.45-38.4 U mL -1 ) and glycerol-3-phosphate-dehydrogenase (1.45-3.82 U mL -1 ) were dissolved in GlyGly buffer (50 mM, pH 7.0) in a 1 mL cuvette at room temperature. Absorbance change was monitored at 340 nm. After 60 sec equilibration FSA wt (175 µg mL -1 ) was added and monitoring was continued. After another 140 sec potential effectors were added (Table 9 ) and the measurement continued. 
